Randomized, open-label, phase 2a study to evaluate the contribution of artefenomel to the clinical and parasiticidal activity of artefenomel plus ferroquine in African patients with uncomplicated Plasmodium falciparum malaria
一项随机、开放标签的 2a 期研究,旨在评估阿特芬诺梅对阿特芬诺梅联合菲罗喹治疗非洲无并发症恶性疟疾患者的临床疗效和杀寄生虫活性的贡献。
期刊:Malaria Journal
影响因子:3
doi:10.1186/s12936-022-04420-2
Gansane, Adama; Lingani, Moussa; Yeka, Adoke; Nahum, Alain; Bouyou-Akotet, Marielle; Mombo-Ngoma, Ghyslain; Kaguthi, Grace; Barceló, Catalina; Laurijssens, Bart; Cantalloube, Cathy; Macintyre, Fiona; Djeriou, Elhadj; Jessel, Andreas; Bejuit, Raphaël; Demarest, Helen; Marrast, Anne Claire; Debe, Siaka; Tinto, Halidou; Kibuuka, Afizi; Nahum, Diolinda; Mawili-Mboumba, Denise Patricia; Zoleko-Manego, Rella; Mugenya, Irene; Olewe, Frederick; Duparc, Stephan; Ogutu, Bernhards